Pfizer (PFE) stock in focus as company faces lawsuits over its alleged failure to warn about brain tumor risks linked to Depo ...

A well-known injectable birth control method is under fire after multiple studies linked it to a specific kind of brain tumor, and now, lawsuits are piling up against the drugmaker. […] The post ...

A new study has linked a type of injectable birth control with meningioma. The manufacturer says the claims are “without ...

Wall Street ended higher on Friday, capping off a strong week that saw both the Nasdaq Composite and S&P 500 finish the week ...

According to Pfizer Inc., only two Depo-Provera lawsuits had been filed in the Philadelphia Court of Common Pleas as of the company's May 29 petition submission. However, one of those actions had ...

Depo-Provera is a birth control shot that is injected every three months and features a type of progestin hormone called ...

Back then, Pfizer said giving its subcutaneous PD-1 inhibitor sasanlimab and Bacillus Calmette-Guérin (BCG) as a first-line treatment for high-risk, non-muscle invasive bladder cancer increased ...